|
Parameters
|
Total
|
Postmenopausal
|
Premenopausal
|
P value
|
|---|
|
(n = 250)
|
(n = 107)
|
(n = 143)
|
|---|
|
WHO
|
|
Central Obesity
|
177(70.8%)
|
94(87.9%)
|
83(58.0%)
|
<0.0001
|
|
Raised Fasting Glucose
|
39(15.6%)
|
30(28.0%)
|
9(6.3%)
|
<0.0001
|
|
Raised Triglyceride
|
24(9.6%)
|
15(14.0%)
|
9(6.3%)
|
0.0507
|
|
Raised Blood Pressure
|
109(43.6%)
|
64(59.8%)
|
45(31.5%)
|
<0.0001
|
|
Reduced HDL-C
|
47(18.8%)
|
26(24.3%)
|
21(14.7%)
|
0.0710
|
|
NCEP ATP III
|
|
Abdominal Obesity
|
160(64.0%)
|
86(80.4%)
|
74(51.7%)
|
<0.0001
|
|
Raised Fasting Glucose
|
62(24.8%)
|
39(36.5%)
|
23(16.1%)
|
0.0003
|
|
Raised Triglyceride
|
24(9.6%)
|
15(14.0%)
|
9(6.3%)
|
0.0507
|
|
Raised Blood Pressure
|
160(64.0%)
|
89(83.2%)
|
71(49.7%)
|
<0.0001
|
|
Reduced HDL-C
|
91(36.4%)
|
45(42.1%)
|
46(32.2%)
|
0.1132
|
|
IDF
|
|
Abdominal Obesity
|
215(86.0%)
|
102(95.3%)
|
113(79.0%)
|
0.0002
|
|
Raised Fasting Glucose
|
62(24.8%)
|
39(36.5%)
|
23(16.1%)
|
0.0003
|
|
Raised Triglyceride
|
24(9.6%)
|
15(14.0%)
|
9(6.3%)
|
0.0507
|
|
Raised Blood Pressure
|
160(64.0%)
|
89(83.2%)
|
71(49.7%)
|
<0.0001
|
|
Reduced HDL-C
|
91(36.4%)
|
45(42.1%)
|
46(32.2%)
|
0.1132
|
|
H_MS
|
|
Abdominal Obesity
|
215(86.0%)
|
102(95.3%)
|
113(79.0%)
|
0.0002
|
|
Raised Fasting Glucose
|
62(24.8%)
|
39(36.5%)
|
23(16.1%)
|
0.0003
|
|
Raised Triglyceride
|
24(9.6%)
|
15(14.0%)
|
9(6.3%)
|
0.0507
|
|
Raised Blood Pressure
|
160(64.0%)
|
89(83.2%)
|
71(49.7%)
|
<0.0001
|
|
Reduced HDL-C
|
91(36.4%)
|
45(42.1%)
|
46(32.2%)
|
0.1132
|
- Data are presented as proportion with corresponding percentages in parenthesis. The proportions were compared using Fischer’s exact test.
